A pivotal role of FOS-mediated BECN1/Beclin 1 upregulation in dopamine D2 and D3 receptor agonist-induced autophagy activation

References

• Bradbury J. Alpha-synuclein gene triplication discovered in Parkinson disease. Lancet Neurol 2003; 2:715; PMID:14649238; http://dx.doi.org/10.1016/S1474-4422(03)00601-X
   PubMed Web of Science ®Google Scholar
• Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson disease. Lancet 2004; 364:1167-9; PMID:15451224; http://dx.doi.org/10.1016/S0140-6736(04)17103-1
   PubMed Web of Science ®Google Scholar
• Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schöls L, Riess O, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson disease. Nat Genet 1998; 18:106-8; PMID:9462735; http://dx.doi.org/10.1038/ng0298-106
   PubMed Web of Science ®Google Scholar
• Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL. Human α-synuclein-harboring familial Parkinson disease-linked Ala-53 –> Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 2002; 99:8968-73; PMID:12084935; http://dx.doi.org/10.1073/pnas.132197599
   PubMed Web of Science ®Google Scholar
• Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, et al. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004; 55:164-73; PMID:14755719; http://dx.doi.org/10.1002/ana.10795
   PubMed Web of Science ®Google Scholar
• Rutherford NJ, Moore BD, Golde TE, Giasson BI. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein. J Neurochem 2014; 131:859-67; PMID:24984882; http://dx.doi.org/10.1111/jnc.12806
   PubMed Web of Science ®Google Scholar
• Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J, Tienari PJ, Pöyhönen M, Paetau A. Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson disease-type pathology. Neurobiol Aging 2014; 35:2180 e1-5; PMID:24746362; http://dx.doi.org/10.1016/j.neurobiolaging.2014.03.024
   PubMed Web of Science ®Google Scholar
• Xilouri M, Stefanis L. Autophagic pathways in Parkinson disease and related disorders. Expert Rev Mol Med 2011; 13:e8; PMID:21418705; http://dx.doi.org/10.1017/S1462399411001803
   PubMed Web of Science ®Google Scholar
• Pan T, Kondo S, Le W, Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson disease. Brain 2008; 131:1969-78; PMID:18187492; http://dx.doi.org/10.1093/brain/awm318
   PubMed Web of Science ®Google Scholar
• Banerjee R, Beal MF, Thomas B. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci 2010; 33:541-9; PMID:20947179; http://dx.doi.org/10.1016/j.tins.2010.09.001
   PubMed Web of Science ®Google Scholar
• Xilouri M, Vogiatzi T, Vekrellis K, Stefanis L. α-synuclein degradation by autophagic pathways: a potential key to Parkinson disease pathogenesis. Autophagy 2008; 4:917-9; PMID:18708765; http://dx.doi.org/10.4161/auto.6685
   PubMed Web of Science ®Google Scholar
• Tyedmers J, Mogk A, Bukau B. Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 2010; 11:777-88; PMID:20944667; http://dx.doi.org/10.1038/nrm2993
   PubMed Web of Science ®Google Scholar
• Wirawan E, Lippens S, Vanden Berghe T, Romagnoli A, Fimia GM, Piacentini M, Vandenabeele P. Beclin1: a role in membrane dynamics and beyond. Autophagy 2012; 8:6-17; PMID:22170155; http://dx.doi.org/10.4161/auto.8.1.16645
   PubMed Web of Science ®Google Scholar
• Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice. J Clin Invest 2008; 118:2190-9; PMID:18497889
   PubMed Web of Science ®Google Scholar
• Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R, Adame A, Wyss-Coray T, Masliah E. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in α-synuclein models of Parkinson and Lewy body diseases. The J Neurosci 2009; 29:13578-88; PMID:19864570; http://dx.doi.org/10.1523/JNEUROSCI.4390-09.2009
   PubMed Web of Science ®Google Scholar
• Weinmann AS, Bartley SM, Zhang T, Zhang MQ, Farnham PJ. Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol 2001; 21:6820-32; PMID:11564866; http://dx.doi.org/10.1128/MCB.21.20.6820-6832.2001
   PubMed Web of Science ®Google Scholar
• Li DD, Wang LL, Deng R, Tang J, Shen Y, Guo JF, Wang Y, Xia LP, Feng GK, Liu QQ, et al. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene 2009; 28:886-98; PMID:19060920; http://dx.doi.org/10.1038/onc.2008.441
   PubMed Web of Science ®Google Scholar
• Copetti T, Bertoli C, Dalla E, Demarchi F, Schneider C. p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol 2009; 29:2594-608; PMID:19289499; http://dx.doi.org/10.1128/MCB.01396-08
   PubMed Web of Science ®Google Scholar
• Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007; 6:472-83; PMID:18054316; http://dx.doi.org/10.1016/j.cmet.2007.11.004
   PubMed Web of Science ®Google Scholar
• Bohensky J, Shapiro IM, Leshinsky S, Terkhorn SP, Adams CS, Srinivas V. HIF-1 regulation of chondrocyte apoptosis: induction of the autophagic pathway. Autophagy 2007; 3:207-14; PMID:17224629; http://dx.doi.org/10.4161/auto.3708
   PubMed Web of Science ®Google Scholar
• Herrero MT, Pagonabarraga J, Linazasoro G. Neuroprotective role of dopamine agonists: evidence from animal models and clinical studies. Neurologist 2011; 17:S54-66; PMID:22045327; http://dx.doi.org/10.1097/NRL.0b013e31823968fc
   PubMedGoogle Scholar
• Joyce JN, Millan MJ. Dopamine D3 receptor agonists for protection and repair in Parkinson disease. Curr Opin Pharmacol 2007; 7:100-5; PMID:17174156; http://dx.doi.org/10.1016/j.coph.2006.11.004
   PubMed Web of Science ®Google Scholar
• Iida M, Miyazaki I, Tanaka K, Kabuto H, Iwata-Ichikawa E, Ogawa N. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res 1999; 838:51-9; PMID:10446316; http://dx.doi.org/10.1016/S0006-8993(99)01688-1
   PubMed Web of Science ®Google Scholar
• Joyce JN. Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs. Pharmacol Ther 2001; 90:231-59; PMID:11578658; http://dx.doi.org/10.1016/S0163-7258(01)00139-5
   PubMed Web of Science ®Google Scholar
• Li C, Guo Y, Xie W, Li X, Janokovic J, Le W. Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson disease. Neurochem Res 2010; 35:1546-56; PMID:20635141; http://dx.doi.org/10.1007/s11064-010-0214-3
   PubMed Web of Science ®Google Scholar
• Ghislat G, Patron M, Rizzuto R, Knecht E. Withdrawal of essential amino acids increases autophagy by a pathway involving Ca2+/calmodulin-dependent kinase kinase-β (CaMKK-β). J Biol Chem 2012; 287:38625-36; PMID:23027865; http://dx.doi.org/10.1074/jbc.M112.365767
   PubMed Web of Science ®Google Scholar
• Presgraves SP, Ahmed T, Borwege S, Joyce JN. Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotoxicity Res 2004; 5:579-98; http://dx.doi.org/10.1007/BF03033178
   PubMed Web of Science ®Google Scholar
• Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 1988; 54:541-52; PMID:3135940; http://dx.doi.org/10.1016/0092-8674(88)90076-1
   PubMed Web of Science ®Google Scholar
• Fujita Y, Izawa Y, Ali N, Kanematsu Y, Tsuchiya K, Hamano S, Tamaki T, Yoshizumi M. Pramipexole protects against H2O2-induced PC12 cell death. Naunyn-Schmiedeberg's Arch Pharmacol 2006; 372:257-66; http://dx.doi.org/10.1007/s00210-005-0025-2
   Google Scholar
• Mizuno K, Kurokawa K, Ohkuma S. Regulation of type 1 IP(3) receptor expression by dopamine D2-like receptors via AP-1 and NFATc4 activation. Neuropharmacol 2013; 71:264-72; http://dx.doi.org/10.1016/j.neuropharm.2013.03.036
   PubMed Web of Science ®Google Scholar
• Lynch-Day MA, Mao K, Wang K, Zhao M, Klionsky DJ. The role of autophagy in Parkinson disease. Cold Spring Harbor Perspectives Med 2012; 2:a009357; http://dx.doi.org/10.1101/cshperspect.a009357
   PubMed Web of Science ®Google Scholar
• Tan CC, Yu JT, Tan MS, Jiang T, Zhu XC, Tan L. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. Neurobiol Aging 2014; 35:941-57; PMID:24360503; http://dx.doi.org/10.1016/j.neurobiolaging.2013.11.019
   PubMed Web of Science ®Google Scholar
• Cheung ZH, Ip NY. The emerging role of autophagy in Parkinson disease. Mol Brain 2009; 2:29; PMID:19754977; http://dx.doi.org/10.1186/1756-6606-2-29
   PubMed Web of Science ®Google Scholar
• Nixon RA. Autophagy in neurodegenerative disease: friend, foe or turncoat? Trends Neurosci 2006; 29:528-35; PMID:16859759; http://dx.doi.org/10.1016/j.tins.2006.07.003
   PubMed Web of Science ®Google Scholar
• Martinez-Vicente M, Cuervo AM. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 2007; 6:352-61; PMID:17362839; http://dx.doi.org/10.1016/S1474-4422(07)70076-5
   PubMed Web of Science ®Google Scholar
• Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson disease. Histol Histopathol 1997; 12:25-31; PMID:9046040
   PubMed Web of Science ®Google Scholar
• Williams A, Jahreiss L, Sarkar S, Saiki S, Menzies FM, Ravikumar B, Rubinsztein DC. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol 2006; 76:89-101; PMID:17118264; http://dx.doi.org/10.1016/S0070-2153(06)76003-3
   PubMed Web of Science ®Google Scholar
• Lee HJ, Khoshaghideh F, Patel S, Lee SJ. Clearance of α-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 2004; 24:1888-96; PMID:14985429; http://dx.doi.org/10.1523/JNEUROSCI.3809-03.2004
   PubMed Web of Science ®Google Scholar
• Ahmed I, Liang Y, Schools S, Dawson VL, Dawson TM, Savitt JM. Development and characterization of a new Parkinson disease model resulting from impaired autophagy. J Neurosci 2012; 32:16503-9; PMID:23152632; http://dx.doi.org/10.1523/JNEUROSCI.0209-12.2012
   PubMed Web of Science ®Google Scholar
• Lee HJ, Cho ED, Lee KW, Kim JH, Cho SG, Lee SJ. Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein. Exp Mol Med 2013; 45:e22; PMID:23661100; http://dx.doi.org/10.1038/emm.2013.45
   PubMed Web of Science ®Google Scholar
• Poehler AM, Xiang W, Spitzer P, May VE, Meixner H, Rockenstein E, Chutna O, Outeiro TF, Winkler J, Masliah E, et al. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment. Autophagy 2014; 10:2171-92; PMID:25484190; http://dx.doi.org/10.4161/auto.36436
   PubMed Web of Science ®Google Scholar
• Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, Vekrellis K. Cell-produced α-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 2010; 30:6838-51; PMID:20484626; http://dx.doi.org/10.1523/JNEUROSCI.5699-09.2010
   PubMed Web of Science ®Google Scholar
• Decuypere JP, Bultynck G, Parys JB. A dual role for Ca(2+) in autophagy regulation. Cell Calcium 2011; 50:242-50; PMID:21571367; http://dx.doi.org/10.1016/j.ceca.2011.04.001
   PubMed Web of Science ®Google Scholar
• Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, Lichtenberg M, Menzies FM, Ravikumar B, Imarisio S, et al. α-Synuclein impairs macroautophagy: implications for Parkinson disease. J Cell Biol 2010; 190:1023-37; PMID:20855506; http://dx.doi.org/10.1083/jcb.201003122
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy. Science 2004; 305:1292-5; PMID:15333840; http://dx.doi.org/10.1126/science.1101738
   PubMed Web of Science ®Google Scholar
• Song JX, Lu JH, Liu LF, Chen LL, Durairajan SS, Yue Z, Zhang HQ, Li M. HMGB1 is involved in autophagy inhibition caused by SNCA/α-synuclein overexpression: a process modulated by the natural autophagy inducer corynoxine B. Autophagy 2014; 10:144-54; PMID:24178442; http://dx.doi.org/10.4161/auto.26751
   PubMed Web of Science ®Google Scholar
• Yan JQ, Yuan YH, Gao YN, Huang JY, Ma KL, Gao Y, Zhang WQ, Guo XF, Chen NH. Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway. Mol Neurobiol 2014; 50:685-701; PMID:24833599; http://dx.doi.org/10.1007/s12035-014-8738-1
   PubMed Web of Science ®Google Scholar
• Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA. Expression of A53T mutant but not wild-type α-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 2001; 21:9549-60; PMID:11739566
   PubMed Web of Science ®Google Scholar
• Jiang TF, Zhang YJ, Zhou HY, Wang HM, Tian LP, Liu J, Ding JQ, Chen SD. Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy. J Neuroimmune Pharmacol 2013; 8:356-69; PMID:23325107; http://dx.doi.org/10.1007/s11481-012-9431-7
   PubMed Web of Science ®Google Scholar
• Shi CS, Kehrl JH. TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci Signal 2010; 3:ra42; PMID:20501938
   PubMed Web of Science ®Google Scholar
• Zalckvar E, Berissi H, Mizrachy L, Idelchuk Y, Koren I, Eisenstein M, Sabanay H, Pinkas-Kramarski R, Kimchi A. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl−XL and induction of autophagy. EMBO Rep 2009; 10:285-92; PMID:19180116; http://dx.doi.org/10.1038/embor.2008.246
   PubMed Web of Science ®Google Scholar
• Gong C, Qu S, Liu B, Pan S, Jiao Y, Nie Y, Su F, Liu Q, Song E. MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells. Oncogene 2013; 34(1):84-93; PMID:24292682; http://dx.doi.org/10.1038/onc.2013.525
   PubMed Web of Science ®Google Scholar
• Smith WW, Liu Z, Liang Y, Masuda N, Swing DA, Jenkins NA, Copeland NG, Troncoso JC, Pletnikov M, Dawson TM, et al. Synphilin-1 attenuates neuronal degeneration in the A53T α-synuclein transgenic mouse model. Hum Mol Genet 2010; 19:2087-98; PMID:20185556; http://dx.doi.org/10.1093/hmg/ddq086
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Neuronal calcium signaling. Neuron 1998; 21:13-26; PMID:9697848; http://dx.doi.org/10.1016/S0896-6273(00)80510-3
   PubMed Web of Science ®Google Scholar
• Neve KA, Seamans JK, Trantham-Davidson H. Dopamine receptor signaling. J Recept Signal Transduct Res 2004; 24:165-205; PMID:15521361; http://dx.doi.org/10.1081/RRS-200029981
   PubMed Web of Science ®Google Scholar
• Mikoshiba K. The Ins(1,4,5)P3 receptor/Ca2+ channel and its cellular function. Biochem Soc Symp 2007; 74:9-22; PMID:17233576; http://dx.doi.org/10.1042/BSS2007c02
   PubMed Web of Science ®Google Scholar
• Stewart AJ, Morgan K, Farquharson C, Millar RP. Phospholipase C-eta enzymes as putative protein kinase C and Ca2+ signalling components in neuronal and neuroendocrine tissues. Neuroendocrinol 2007; 86:243-8; http://dx.doi.org/10.1159/000107795
   PubMed Web of Science ®Google Scholar
• Clapham DE, Neer EJ. G protein β gamma subunits. Ann Rev Pharmacol Toxicol 1997; 37:167-203; http://dx.doi.org/10.1146/annurev.pharmtox.37.1.167
   PubMed Web of Science ®Google Scholar
• Sato K, Suematsu A, Nakashima T, Takemoto-Kimura S, Aoki K, Morishita Y, Asahara H, Ohya K, Yamaguchi A, Takai T, et al. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med 2006; 12:1410-6; PMID:17128269; http://dx.doi.org/10.1038/nm1515
   PubMed Web of Science ®Google Scholar
• Ling ZD, Robie HC, Tong CW, Carvey PM. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures. J Pharmacol Exp Therapeutics 1999; 289:202-10
   PubMed Web of Science ®Google Scholar
• Ferrari-Toninelli G, Maccarinelli G, Uberti D, Buerger E, Memo M. Mitochondria-targeted antioxidant effects of S(−) and R(+) pramipexole. BMC Pharmacol 2010; 10:2; PMID:20137065; http://dx.doi.org/10.1186/1471-2210-10-2
   PubMedGoogle Scholar
• Schapira AH, McDermott MP, Barone P, Comella CL, Albrecht S, Hsu HH, Massey DH, Mizuno Y, Poewe W, Rascol O, et al. Pramipexole in patients with early Parkinson disease (PROUD): a randomised delayed-start trial. Lancet Neurol 2013; 12:747-55; PMID:23726851; http://dx.doi.org/10.1016/S1474-4422(13)70117-0
   PubMed Web of Science ®Google Scholar
• Crawford GD, Jr., Le WD, Smith RG, Xie WJ, Stefani E, Appel SH. A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci 1992; 12:3392-8; PMID:1356145
   PubMed Web of Science ®Google Scholar
• Wang Y, Jia J, Ao G, Hu L, Liu H, Xiao Y, Du H, Alkayed NJ, Liu CF, Cheng J. Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia. J Neurochem 2014; 129:827-38; PMID:24673410; http://dx.doi.org/10.1111/jnc.12695
   PubMed Web of Science ®Google Scholar
• Wang XH, Wang F, You SJ, Cao YJ, Cao LD, Han Q, Liu CF, Hu LF. Dysregulation of cystathionine gamma-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage. Cell Signal 2013; 25:2255-62; PMID:23872072; http://dx.doi.org/10.1016/j.cellsig.2013.07.010
   PubMed Web of Science ®Google Scholar
• Li D, Shi JJ, Mao CJ, Liu S, Wang JD, Chen J, Wang F, Yang YP, Hu WD, Hu LF, et al. Alteration of dynein function affects α-synuclein degradation via the autophagosome-lysosome pathway. Int J Mol Sci 2013; 14:24242-54; PMID:24351814; http://dx.doi.org/10.3390/ijms141224242
   PubMed Web of Science ®Google Scholar